
In the Molecular Pathology v. U.S. Patent and Trademark Office case, are genes, isolated from a human DNA sequence, sufficiently new and useful to be patented under federal patent law?
Advertisement

In September, 2009, we discussed the possibilities for the government’s help in addressing the ravages of a natural disaster. Then, we didn’t stop to envision the possibility that insurers would simply back out of certain catastrophe coverage markets. Yet, that is just what is happening in Florida, right now.
It's fast, easy and free. By submitting your legal issue, you will be automatically registered as a LegalFish Member Client. If you are already a member, please click here to log in. There is no cost or obligation to you and our service is completely confidential.Click Here to Post Your Case Now!
Advertisement
Advertisement